DPS: Electrocardiograph

Product code DPS covers electrocardiographs, Class II devices regulated under 21 CFR 870.2340 and reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 579 clearances under DPS.
Updated Oct 23, 2026 · Clearances from FDA’s 510(k) database, as of Nov 16, 2026
Product code
DPS
Regulation
21 CFR 870.2340
Class
II
Panel
Cardiovascular
Clearances
579
Most recent
Oct 23, 2026
Median review, last 2 years
243 days

What it covers

Devices that acquire and record the electrical activity of the heart, from diagnostic 12-lead systems to wearable ECG patches, often with software that measures intervals or detects arrhythmias.

Recent clearances

510(k)DeviceApplicantDecisionType
K260640Kinetic Software LibraryMonebo Technologies, Inc.Oct 23, 2026Traditional
K260005MyoVista wavECG (DG-200-B15-003)HeartSciences, Inc.Oct 5, 2026Traditional
K260250QCA 10 Electrocardiograph (QCARD-10); QCA 10W Electrocardiograph (QCARD-10W)QT Medical, Inc.Sep 29, 2026Traditional
K252463SE-1202 Series Electrocardiograph (Model: SE-1202, SE-1202E)Edan Instruments, Inc.Jul 2, 2026Traditional
K251670MAC 7 Resting ECG Analysis SystemGe Medical Systems Information Technologies, Inc.Jan 26, 2026Traditional
K252361AccurECG Analysis System (v2.0)Accurkardia, Inc.Dec 22, 2025Traditional
K252474Withings BeamO (SCT02)WithingsNov 10, 2025Traditional
K250569Cardiologs Holter PlatformPhilips France CommercialAug 6, 2025Traditional
K243252ZBPro DiagnosticZbeats, Inc.Jul 10, 2025Traditional
K243305Masimo W1Masimo CorporationApr 3, 2025Traditional
From FDA’s 510(k) database, as of Nov 16, 2026Export CSV (100 rows free · all 579 with a free account)

Clearances by year

146 DPS 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)5270
20256163
20248260
202310236
20226244
20215135
20206224
20193178
201814221
20179177
201611229
20158178
201411253
201310134
201212117
201122154

Who submits

88 applicants cleared a DPS device since 2011. 48% of the clearances went to applicants in United States, then China (27%), France (5%) and South Korea (4%). By type: Traditional 85%, Special 13% and Abbreviated 2%. 5 went through a third-party review organization.

ApplicantClearances since 2011
Edan Instruments, Inc.13
Ge Medical Systems Information Technologies, Inc.6
Bionet Co., Ltd.5
Mortara Instrument, Inc.5
Shenzhen Biocare Bio-Medical Equipment Co., Ltd.5
AliveCor, Inc.4
Philips Medical Systems4
Shenzhen Biocare Electronics Co., Ltd.4

Testing FDA usually expects

  • Electrical safety and EMC per IEC 60601-1 and IEC 60601-1-2
  • ECG performance per IEC 60601-2-25 (diagnostic) or IEC 60601-2-47 (ambulatory)
  • Arrhythmia algorithm performance against reference databases per ANSI/AAMI EC57
  • Biocompatibility of skin-contacting parts per ISO 10993-1

Standards

Ask about DPS

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about DPS

What is FDA product code DPS?

Product code DPS covers electrocardiographs, Class II devices regulated under 21 CFR 870.2340 and reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 579 clearances under DPS.

How many 510(k) clearances are there under DPS?

FDA’s 510(k) database listed 579 clearances under DPS as of Nov 16, 2026, 146 of them decided since 2011; the most recent decision was Oct 23, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a DPS 510(k)?

For the 12 DPS clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 243 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most DPS clearances?

Since 2011: Edan Instruments, Inc. (13), Ge Medical Systems Information Technologies, Inc. (6), Bionet Co., Ltd. (5), Mortara Instrument, Inc. (5) and Shenzhen Biocare Bio-Medical Equipment Co., Ltd. (5). 88 applicants have cleared a DPS device in that time.

What testing do DPS submissions include?

Recent DPS 510(k) summaries typically describe: electrical safety and EMC per IEC 60601-1 and IEC 60601-1-2; eCG performance per IEC 60601-2-25 (diagnostic) or IEC 60601-2-47 (ambulatory); arrhythmia algorithm performance against reference databases per ANSI/AAMI EC57; biocompatibility of skin-contacting parts per ISO 10993-1. Check the summaries of your own predicates for what they submitted.

Sources

  1. FDA product classification: DPS · Product Classification database
  2. 21 CFR 870.2340: Electrocardiograph · eCFR
  3. openFDA 510(k) query for DPS · run Nov 16, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow DPSGet an email when FDA clears, recalls or publishes guidance for electrocardiographs.

Know what FDA already cleared.